Your browser doesn't support javascript.
loading
Anlotinib for the Treatment of Patients with Locally Advanced or Metastatic Medullary Thyroid Cancer.
Sun, Yongkun; Du, Feng; Gao, Ming; Ji, Qinghai; Li, Zhendong; Zhang, Yuan; Guo, Zhuming; Wang, Jun; Chen, Xiangjin; Wang, Jinwan; Chi, Yihebali; Tang, Pingzhang.
Afiliación
  • Sun Y; 1 Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital , Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China .
  • Du F; 2 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), The VIPII Gastrointestinal Cancer Division of Medical Department, Peking University Cancer Hospital and Institute , Beijing, China .
  • Gao M; 3 Department of Thyroid and Neck Oncology, Tianjin Medical University Cancer Institute and Hospital , Tianjin, China .
  • Ji Q; 4 Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai, China .
  • Li Z; 5 Department of Head and Neck Surgery, Liaoning Cancer Hospital and Institute , Shenyang, China .
  • Zhang Y; 6 Department of Head and Neck Surgery, Jiangsu Cancer Hospital , Nanjing, China .
  • Guo Z; 7 Department of Head and Neck Surgery, Sun Yat-sen University Cancer Center , Guangzhou, China .
  • Wang J; 8 Department of Thyroid and Breast Surgery, Gansu Provincial Cancer Hospital , Lanzhou, China .
  • Chen X; 9 Department of Head and Neck Surgery, First Affiliated Hospital of Fujian Medical University , Fuzhou, China .
  • Wang J; 1 Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital , Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China .
  • Chi Y; 1 Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital , Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China .
  • Tang P; 1 Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital , Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China .
Thyroid ; 28(11): 1455-1461, 2018 11.
Article en En | MEDLINE | ID: mdl-30142994
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_endocrine_disorders / 6_thyroid_cancer Asunto principal: Quinolinas / Neoplasias de la Tiroides / Carcinoma Medular / Indoles / Antineoplásicos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Thyroid Asunto de la revista: ENDOCRINOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_endocrine_disorders / 6_thyroid_cancer Asunto principal: Quinolinas / Neoplasias de la Tiroides / Carcinoma Medular / Indoles / Antineoplásicos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Thyroid Asunto de la revista: ENDOCRINOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: China